Research

Publications

At Usona, our exploration of psychedelic compounds is guided by discovery through scientific rigor. Our Medicinal Chemistry team continues publishing impactful research articles in collaboration with scientists around the globe.

Usona Publications

Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and Psychoplastogens

Kargbo, R. B. ACS Med. Chem. Lett. 2024, DOI:org/10.1021/acsmedchemlett.4c00003

SEE THE ARTICLE

Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders

Kargbo, R. B. ACS Med. Chem. Lett. 2024, 15 (1), 12–14

SEE THE ARTICLE

Small-Molecule Heterocyclic Compounds: Gq-Biased Agonists for the 5-HT2A Receptor in Neuropsychiatric Treatment

Kargbo, R. B. ACS Med. Chem. Lett. 2023, 14 (11), 1498–1500

SEE THE ARTICLE

Neurosteroids and Postpartum Depression: The Mechanism, Efficacy, and Approval of Brexanolone and Zurzuvae

Kargbo, R. B. ACS Med. Chem. Lett. 2023, 14 (10), 1326–1328

SEE THE ARTICLE

Microbiome: The Next Frontier in Psychedelic Renaissance

Kargbo, R. B. J. Xenobiot. 2023, 13 (3), 386-401.

SEE THE ARTICLE

Swim in the Chiral Pool: MDMA and MDA Enantiomers from Alanine-Derived Precursors

Sherwood, A. M.; Burkhartzmeyer, E. K.; Williamson, S. E.; Faley, M. T. ACS Omega 2023, 8 (24), 22132–22137.

SEE THE ARTICLE

5-MeO-DMT Modifies Innate Behaviors and Promotes Structural Neural Plasticity in Mice

Jefferson, S. J.; Gregg, I.; Dibbs, M.; Liao, C.; Wu, H.; Davoudian, P. A.; Woodburn, S. C.; Wehrle, P. H.; Sprouse, J. S.; Sherwood, A. M.; Kaye, A. P.; Pittenger, C.; Kwan, A. C. Neuropsychopharmacology 2023, 48 (9), 1257–1266.

SEE THE ARTICLE

Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?

Cotten, S. W.; Strathmann, F. G.; Barrett, F. S.; Labay, L.; Mullally, J.; Sherwood, A. M.; Wiegand, F. Clin. Chem. 2023, 69 (4), 319–326.

SEE THE ARTICLE